LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 233 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $200,000 | -32.7% | 2,325 | -10.6% | 0.00% | -100.0% |
| Q2 2019 | $297,000 | +12.9% | 2,602 | +24.4% | 0.00% | 0.0% |
| Q1 2019 | $263,000 | -25.9% | 2,091 | +61.6% | 0.00% | -50.0% |
| Q3 2018 | $355,000 | -1.7% | 1,294 | -25.7% | 0.00% | 0.0% |
| Q2 2018 | $361,000 | +57.6% | 1,742 | +25.9% | 0.00% | +100.0% |
| Q1 2018 | $229,000 | +11.2% | 1,384 | -19.7% | 0.00% | -50.0% |
| Q2 2016 | $206,000 | -78.3% | 1,724 | -84.4% | 0.00% | -87.5% |
| Q3 2015 | $949,000 | – | 11,083 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $6,891 | 2.63% |
| VILLERE ST DENIS J & CO LLC | 438,161 | $26,254,607 | 2.24% |
| RICE HALL JAMES & ASSOCIATES, LLC | 282,961 | $16,955,023 | 1.08% |
| Chicago Capital, LLC | 360,345 | $21,591,884 | 1.01% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 206,399 | $12,367,428 | 0.53% |
| Smith, Graham & Co., Investment Advisors, LP | 61,849 | $3,705,992 | 0.46% |
| Stephens Investment Management Group LLC | 467,564 | $28,016,435 | 0.46% |
| Jackson Creek Investment Advisors LLC | 13,657 | $818 | 0.34% |
| Court Place Advisors, LLC | 15,133 | $906,769 | 0.32% |
| Ziegler Capital Management, LLC | 123,158 | $7,379,176 | 0.30% |